Zobrazeno 1 - 6 of 6 pro vyhledávání: '"Dominique Tersago"'
1
An affinity-enhanced, broadly neutralizing heavy chain-only antibody protects against SARS-CoV-2 infection in animal models
Autor: Iebe Rossey, Sandrine Vanmarcke, Sieglinde De Cae, Joana Rocha-Pereira, Xavier Saelens, Martin Schwemmle, Wander Van Breedam, Andrew Popplewell, Nick Devoogdt, Laurens Liesenborghs, Dominique Tersago, Annette Ohnemus, Kenny Roose, Simon Devos, Julius Beer, Piet Maes, Frank Peelman, Daniel Schnepf, Peter Staeheli, Sofie Jacobs, Wim Nerinckx, Massimiliano Germani, Catelijne Stortelers, George D. Moschonas, Kevin Brady, Alison Turner, Rana Abdelnabi, Daria Fijalkowska, Wannes Weyts, Isabel Remory, Leen Delang, Lana Langendries, Laura Seldeslachts, João Paulo Portela Catani, Bruno Dombrecht, Dries Van Herpe, Dirk Jochmans, Loes van Schie, Koen Sedeyn, Greetje Vande Velde, Chiara Lonigro, Sarah Creytens, Xin Zhang, Bert Schepens, Sebastiaan ter Horst, Kai Dallmeier, Hannah Eeckhaut, Caroline Shi-Yan Foo, Jimmy Borloo, Robbert Boudewijns, Suzanne J.F. Kaptein, James Heads, Nico Callewaert, Birgit Weynand, Mark Ellis, Ana Filipa Oliveira, Annelies Van Hecke, Gitte Michielsen, Dorien De Vlieger, Jackeline Cecilia Zavala Marchan, Alistair Henry, Johan Neyts, Hendrik Jan Thibaut
Publikováno v: SCIENCE TRANSLATIONAL MEDICINE
Broadly neutralizing antibodies are an important treatment for individuals with coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Antibody-based therapeutics are also essential for pandemic pr
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3830e9b60d433a409a79548892804d43
https://lirias.kuleuven.be/handle/123456789/682263
Zobrazit plný text záznamu
2
Drug development of an affinity enhanced, broadly neutralizing heavy chain-only antibody that restricts SARS-CoV-2 in rodents
Autor: Piet Maes, Martin Schwemmle, Allison Turner, Annette Ohnemus, Wander Van Breedam, Greetje Vande Velde, Bert Schepens, Sieglinde De Cae, Suzanne J.F. Kaptein, Nick Devoogdt, James Heads, Mark Ellis, Peter Staeheli, Gitte Michielsen, Bruno Dombrecht, Julius Beer, Dominique Tersago, Robbert Boudewijns, Sofie Jacobs, Leen Delang, Dries Van Herpe, João Paulo Portela Catani, Dirk Jochmans, Alistair Henry, Rana Abdelnabi, Nico Callewaert, Birgit Weynand, Sandrine Vanmarcke, Sarah Creytens, Simon Devos, George D. Moschonas, Isabel Remory, Annelies Van Hecke, Lana Langendries, Daniel Schnepf, Catelijne Stortelers, Koen Sedeyn, Ana Filipa Oliveira, Laura Seldeslachts, Xin Zhang, Xavier Saelens, Loes van Schie, Laurens Liesenborghs, Dorien De Vlieger, Chiara Lonigro, Frank Peelman, Massimiliano Germano, Joana Rocha-Pereira, Kevin Brady, Wannes Weyts, Hendrik Jan Tibaut, Sebastiaan ter Horst, Kai Dallmeier, Hannah Eeckhaut, Jackeline Cecilia Zavala Marchan, Kenny Roose, Johan Neyts, Wim Nerinckx, Daria Fijalkowska, Andy Popplewell, Iebe Rossey, Caroline Shi-Yan Foo, Jimmy Borloo
We have identified camelid single-domain antibodies (VHHs) that cross-neutralize SARS-CoV-1 and −2, such as VHH72, which binds to a unique highly conserved epitope in the viral receptor-binding domain (RBD) that is difficult to access for human ant
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::d213f47d21cc67cf73c8fd52a12112a4
https://doi.org/10.1101/2021.03.08.433449
Zobrazit plný text záznamu
5
Caplacizumab for Acquired Thrombotic Thrombocytopenic Purpura
Autor: Flora, Peyvandi, Marie, Scully, Johanna A, Kremer Hovinga, Spero, Cataland, Paul, Knöbl, Haifeng, Wu, Andrea, Artoni, John-Paul, Westwood, Magnus, Mansouri Taleghani, Bernd, Jilma, Filip, Callewaert, Hans, Ulrichts, Christian, Duby, Dominique, Tersago, Majed, Refaai
Publikováno v: Peyvandi, Flora; Scully, Marie; Kremer Hovinga, Johanna Anna; Cataland, Spero; Knöbl, Paul; Wu, Haifeng; Artoni, Andrea; Westwood, John-Paul; Mansouri Taleghani, Magnus; Jilma, Bernd; Callewaert, Filip; Ulrichts, Hans; Duby, Christian; Tersago, Dominique (2016). Caplacizumab for Acquired Thrombotic Thrombocytopenic Purpura. New England journal of medicine NEJM, 374(6), pp. 511-522. Massachusetts Medical Society MMS 10.1056/NEJMoa1505533
The New England journal of medicine
NEW ENGLAND JOURNAL OF MEDICINE
r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
instname
BACKGROUND Acquired thrombotic thrombocytopenic purpura (TTP) is caused by aggregation of platelets on ultralarge von Willebrand factor multimers. This microvascular thrombosis causes multiorgan ischemia with potentially life-threatening complication
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::063872941a19fa935edad4522d375c94
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje